Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 679-526-3 | CAS number: 337906-36-2
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Overall, the genotoxicity of 2-methoxy-methyl-p-phenylenediamine is sufficiently investigated in valid genotoxicity tests for the 3 endpoints of genotoxicity: gene utations, chromosome aberrations and aneuploidy.
2-Methoxy-methyl-p-phenylenediamine was mutagenic in all in vitro tests performed. It did induce gene mutations both in a gene mutation test in bacteria as well as in a mouse
lymphoma assay in mammalian cells and chromosome aberrations in an in vitro micronucleus test although these positive findings were considered of questionable biological importance. The finding in the mouse lymphoma assay that both the number of large and small colonies increased and the ratio large/small colonies decreased indicated to a clastogenic effect of 2-methoxy-methyl-p-phenylenediamine next to a mutagenic one.
The positive findings from the in vitro tests could not be confirmed in in vivo tests. In an UDS test exposure to 2-methoxy-methyl-p-phenylenediamine did not result in unscheduled DNA synthesis in liver of rats. In an in vivo micronucleus test, an increase in bone marrow cells with micronuclei was not seen indicating that 2-methoxy-methyl-p- phenylenediamine is not clastogenic nor aneugenic in this test. The results of a comet assay, an indicator test covering gene mutations and chromosome aberrations, confirmed that 2-methoxy-methylp-phenylenediamine is not genotoxic (mutagenic and clastogenic) in stomach cells and bladder epithelial cells of rats.
Although the results obtained in the comet assay for liver cells were equivocal, the negative UDS test covers for DNA damage in these cells.
Consequently, based on these tests, 2-methoxy-methyl-p-phenylenediamine can be considered to have no genotoxic potential and additional tests are unnecessary.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
In in vitro studies some mutagenic effects were reported, but this was not confirmed in in vivo studies therefore, the substance was not considered as genotoxic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
